Genetics of rheumatoid arthritis: 2018 status

Annals of the Rheumatic Diseases

Volumn 78, Issue 4, 2019, Pages 446-453

  Okada, Yukinori ^a,b   Eyre, Stephen ^c   Suzuki, Akari ^b   Kochi, Yuta ^b   Yamamoto, Kazuhiko ^b  

^a OSAKA UNIVERSITY   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

autoimmune diseases; gene polymorphism; rheumatoid arthritis

Indexed keywords

ANTIGEN PEPTIDE TRANSPORTER 2; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ALLELE; ATAC SEQUENCING; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN IMMUNOPRECIPITATION SEQUENCING; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNASEHS SEQUENCING; EXPRESSION QUANTITATIVE TRAIT LOCUS; GENE; GENE EXPRESSION LEVEL; GENE LOCUS; GENETIC BACKGROUND; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HLA A GENE; HLA B GENE; HLA C GENE; HLA DMA GENE; HLA DMB GENE; HLA DOA GENE; HLA DOB GENE; HLA DPA1 GENE; HLA DPB1 GENE; HLA DQA1 GENE; HLA DQB1 GENE; HLA DRA GENE; HLA DRB1 GENE; HLA E GENE; HLA F GENE; HLA G GENE; HLA H GENE; HLA J GENE; HLA K GENE; HLA L GENE; HLA V GENE; HLA Y GENE; HUMAN; LINKAGE DISEQUILIBRIUM SCORE; MICA GENE; MICB GENE; MICROARRAY ANALYSIS; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; PATHOGENESIS; PHENOTYPE; PLEIOTROPY; POLYGENIC RISK SCORE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TAP1 GENE; TAP2 GENE; GENETIC PREDISPOSITION; MAJOR HISTOCOMPATIBILITY COMPLEX; QUANTITATIVE TRAIT LOCUS;

ARTHRITIS, RHEUMATOID; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-DRB1 CHAINS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; QUANTITATIVE TRAIT LOCI;

EID: 85058332058     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2018-213678     Document Type: Review

References (75)

1. Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers 2018;4:18001.
2. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000;43:30-7.
3. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007;447:661-78.
4. Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014;506:376-81.
5. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 2015;348:648-60.
6. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
7. International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-96.
8. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-4.
9. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395-402.
10. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005;37:478-85.
11. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477-82.
12. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007;357:1199-209.
13. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
14. Plenge RM, Padyukov L, Remmers EF, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4, 000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005;77:1044-60.
15. Ikari K, Kuwahara M, Nakamura T, et al. Association between PADI4 and rheumatoid arthritis: A replication study. Arthritis Rheum 2005;52:3054-7.
16. Abecasis GR, Auton A, BrooksLD, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012;491:56-65.
17. Li Y, Willer C, Sanna S, et al. Genotype imputation. Annu Rev Genomics Hum Genet 2009;10:387-406.
18. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42:508-14.
19. Okada Y, Terao C, Ikari K, et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 2012;44:511-6.
20. Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012;44:1336-40.
21. Kochi Y, Thabet MM, Suzuki A, et al. PADI4 polymorphism predisposes male smokers to rheumatoid arthritis. Ann Rheum Dis 2011;70:512-5.
22. Kurreeman FA, Stahl EA, Okada Y, et al. Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12. Am J Hum Genet 2012;90:524-32.
23. Kim K, Bang SY, Ikari K, et al. Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis. Sci Rep 2016;6:27563.
24. Okada Y, Muramatsu T, Suita N, et al. Significant impact of miRNA-target gene networks on genetics of human complex traits. Sci Rep 2016;6:22223.
25. Sakaue S, Hirata J, Maeda Y, et al. Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity. Nucleic Acids Res 2018.
26. Zhang Y, Qi G, Park JH, et al. Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits. Nat Genet 2018;50:1318-26.
27. Saxena R, Plenge RM, Bjonnes AC, et al. A multinational arab genome-wide association study identifies new genetic associations for rheumatoid arthritis. Arthritis Rheumatol 2017;69:976-85.
28. Danila MI, Laufer VA, Reynolds RJ. Dense Genotyping of Immune-Related Regions Identifies Loci for Rheumatoid Arthritis Risk and Damage in African Americans. Mol Med 2017;23:1-187.
29. Traylor M, Curtis C, Patel H, et al. Genetic and environmental risk factors for rheumatoid arthritis in a UK African ancestry population: The GENRA case-control study. Rheumatology 2017;56:1282-92.
30. López Herráez D, Martínez-Bueno M, Riba L, et al. Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region. Arthritis Rheum 2013;65:1457-67.
31. Pickrell JK, Berisa T, Liu JZ, et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet 2016;48:709-17.
32. Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011;7:e1002004.
33. Chatterjee N, Shi J, García-Closas M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet 2016;17:392-406.
34. Stahl EA, Wegmann D, Trynka G, et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 2012;44:483-9.
35. Finucane HK, Bulik-Sullivan B, Gusev A, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet 2015;47:1228-35.
36. Lee SH, Byrne EM, Hultman CM, et al. New data and an old puzzle: The negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol 2015;44:1706-21.
37. Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet 2015;47:1236-41.
38. Oken RJ, Schulzer M. At issue: Schizophrenia and rheumatoid arthritis: The negative association revisited. Schizophr Bull 1999;25:625-38.
39. van der Woude D, Houwing-Duistermaat JJ, Toes RE, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative rheumatoid arthritis. Arthritis Rheum 2009;60:916-23.
40. Kochi Y, Yamada R, Kobayashi K, et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional susceptibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum 2004;50:63-71.
41. Padyukov L, Seielstad M, Ong RT, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011;70:259-65.
42. The International HIV Controllers Study. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551-7.
43. Jia X, Han B, Onengut-Gumuscu S, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 2013;8:e64683.
44. Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;44:291-6.
45. Okada Y, Kim K, Han B, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 2014;23:6916-26.
46. Han B, Diogo D, Eyre S, et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet 2014;94:522-32.
47. Reynolds RJ, Ahmed AF, Danila MI, et al. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: Hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol 2014;66:3274-82.
48. Okada Y, Suzuki A, Ikari K, et al. Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis. Am J Hum Genet 2016;99:366-74.
49. Hirata J, Hosomichi K, Sakaue S. Genetic and phenotypic landscape of the MHC region in the Japanese population. Nat Genet In Press.
50. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-8.
51. Bottini N, Vang T, Cucca F, et al. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006;18:207-13.
52. Rieck M, Arechiga A, Onengut-Gumuscu S, et al. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179:4704-10.
53. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-9.
54. Gregersen PK, Lee HS, Batliwalla F, et al. PTPN22: Setting thresholds for autoimmunity. Semin Immunol 2006;18:214-23.
55. Vang T, Landskron J, Viken MK, et al. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses. Hum Immunol 2013;74:574-85.
56. Wang Y, Ewart D, Crabtree JN, et al. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus. Arthritis Rheumatol 2015;67:2403-14.
57. Chang HH, Dwivedi N, Nicholas AP, et al. The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthritis Rheumatol 2015;67:2323-34.
58. Dai X, James RG, Habib T, et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest 2013;123:2024-36.
59. Zhang J, Zahir N, Jiang Q, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 2011;43:902-7.
60. Hagberg N, Joelsson M, Leonard D, et al. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE. Ann Rheum Dis 2018;77:1070-7.
61. Kochi Y, Okada Y, Suzuki A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010;42:515-9.
62. Ishigaki K, Kochi Y, Suzuki A, et al. Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis. Nat Genet 2017;49:1120-5.
63. Honne K, Hallgrímsdóttir I, Wu C, et al. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis. Arthritis Res Ther 2016;18:12.
64. Umicevic Mirkov M, Cui J, Vermeulen SH, et al. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Ann Rheum Dis 2013;72:1375-81.
65. Cui J, Stahl EA, Saevarsdottir S, et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet 2013;9:e1003394.
66. Plant D, Bowes J, Potter C, et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 2011;63:645-53.
67. Julià A, Fernandez-Nebro A, Blanco F, et al. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis. Pharmacogenomics J 2016;16:147-50.
68. Sieberts SK, Zhu F, García-García J, et al. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nat Commun 2016;7:12460.
69. Farh KK, Marson A, Zhu J, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015;518:337-43.
70. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
71. Stunnenberg HG, Hirst M, Abrignani S. The international human epigenome consortium: A blueprint for scientific collaboration and discovery. Cell 2016;167:167-149.
72. Kundaje A, Meuleman W, Ernst J, et al. Integrative analysis of 111 reference human epigenomes. Nature 2015;518:317-30.
73. Schmitt AD, Hu M, Ren B, et al. Genome-wide mapping and analysis of chromosome architecture. Nat Rev Mol Cell Biol 2016;17:743-55.
74. Martin P, McGovern A, Orozco G, et al. Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat Commun 2015;6:10069.
75. Simeonov DR, Gowen BG, Boontanrart M, et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 2017;549:111-5.